Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Kyverna says long-term data bolster FDA submission for rare autoimmune CAR-T

Kyverna Therapeutics touted positive one-year results on Thursday in patients with a rare autoimmune disorder called stiff person syndrome. The condition affects about 6,000 patients in the US, causing painful muscle spasms and stiffness. Kyverna’s ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Thursday 24 September →